Seattle, May 22, 2013 - Cardeas Pharma Corporation, a biopharmaceutical company focused on the development of innovative therapies for the treatment of multi-drug resistant (MDR) bacterial infections, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback